Acquisitions, Dispositions, and Funded Research and Development Arrangements - Acquisition Activity (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Apr. 25, 2025 |
Apr. 26, 2024 |
Apr. 28, 2023 |
|
| Business Acquisition [Line Items] | |||
| Goodwill | $ 41,737 | $ 40,986 | $ 41,425 |
| Contingent consideration | 81 | 149 | $ 206 |
| Business combinations | |||
| Business Acquisition [Line Items] | |||
| Total consideration for the transaction, net of cash acquired | 128 | 335 | |
| Assets acquired | 159 | 338 | |
| Liabilities assumed | 31 | 3 | |
| Goodwill | 108 | 131 | |
| Contingent consideration | 20 | 30 | |
| Goodwill, net of tax | 51 | ||
| Goodwill, non deductible amount | 80 | ||
| Business combinations | IPR&D | |||
| Business Acquisition [Line Items] | |||
| Indefinite-lived intangible assets | $ 50 | 150 | |
| Business combinations | Technology-Based Intangible Assets | |||
| Business Acquisition [Line Items] | |||
| Intangible assets acquired | $ 29 | ||
| Intangible assets, estimated useful life | 10 years | ||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of assets acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after tax, of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. No definition available.
|
| X | ||||||||||
- Definition Portion of goodwill not yet allocated to reportable segments. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|